MS
TBIO

Maven Securities’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Maven Securities’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,611
Closed -$723K – 1213
2021
Q3 		$723K Sell
3,611
-2,665
-42% -$676K 0.02% 545
2021
Q2 		$2.12M Buy
+6,276
New +$2.22M 0.09% 216

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Maven Securities's TBIO Position: Q4 2021 in Review

Maven Securities sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2021, closing a stake of 3,611 shares — an estimated $723K sold.

Maven Securities first reported a position in TBIO in Q2 2021 and held it in 2 quarters. The position peaked at $2.12M in Q2 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q4 2021.

  • Maven Securities reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Maven Securities sold 3,611 Telesis Bio, Inc. Common Stock shares in Q4 2021, an estimated $723K.
  • Maven Securities first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Maven Securities's Telesis Bio, Inc. Common Stock position peaked at $2.12M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2021.

Based on Maven Securities's 13F filing for Q4 2021, filed 14 Feb 2022.